The Finnish Faecal Microbiota Transplantation Study (FINFMT) — FINFMT

Faecal Microbiota Transplantation Clinical Trial

Official title:
Long Term Safety and Efficacy of Faecal Microbiota Transplantation: a Nationwide Obeservational Study

Status Recruiting

Clinical Trial Summary

The objective of the study is to follow up the long term effects of faecal microbiota tranplantation (FMT). All the over 18 years old patients receiving FMT and not included in other trials meet inclusion criteria to this study. Patients will be asked for a written consent. The outcome and possible side effects of the FMT will be followed by blood and feces samples for one year and with questionaires up to ten years after the FMT.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Faecal Microbiota Transplantation

Clinical Trial Details

NCT number	NCT03732131
Study type	Observational
Source	Joint Authority for Päijät-Häme Social and Health Care
Contact	Perttu Lahtinen, MD
Phone	+358-3-819 11
Email	perttu.lahtinen@phhyky.fi
Status	Recruiting
Phase
Start date	October 18, 2018
Completion date	January 15, 2029

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05447533` - Clostridioides Difficile and Frailty	N/A
Recruiting	`NCT05742074` - The Effect of Faecal Microbiota Transplantation (FMT) on Eradication of Multidrug Resistant Organisms (MRO) in Intestinal Carriers	N/A
Recruiting	`NCT03477032` - FMT in Inflammatory Bowel Disease